Noevir Holdings Co., Ltd.
4928・Prime Market・Chemicals
Noevir Holdings Co., Ltd.4928
Noevir Holdings Co., Ltd.4928
Reference Indicators
Market Cap
1,569¥100M
P/E (Forecast)
19.1x
P/B
2.9x
Dividend Yield (Forecast)
5.01%
ROE
15.0%
EV/EBITDA
10.9x
Financial Summary
Unit: ¥M
| Item | 2021Sep 2021 | 2022Sep 2022 | 2023Sep 2023 | 2024Sep 2024 | 2025Sep 2025 |
|---|---|---|---|---|---|
Net Sales | 51,272 | 61,143 | 62,552 | 63,823 | 64,724 |
Cost of Sales | 18,241 | 19,050 | 19,988 | 20,666 | 21,446 |
Gross Profit | 33,031 | 42,093 | 42,564 | 43,156 | 43,278 |
SG&A Expenses | 24,473 | 31,977 | 31,540 | 31,733 | 32,202 |
Operating Income | 8,557 | 10,115 | 11,024 | 11,423 | 11,075 |
Non-operating Income | 455 | 291 | 271 | 200 | 702 |
Non-operating Expenses | 41 | 0 | 0 | 29 | 3 |
Ordinary Income | 8,972 | 10,406 | 11,295 | 11,594 | 11,774 |
Extraordinary Income | 6 | 1,083 | 7 | 25 | 108 |
Extraordinary Losses | 12 | 329 | 4 | 0 | 3 |
Pre-tax Income | 8,966 | 11,161 | 11,298 | 11,619 | 11,879 |
Income Taxes | 2,506 | 3,506 | 3,484 | 3,530 | 3,690 |
Net Income | 6,383 | 7,589 | 7,673 | 7,970 | 8,030 |
EBITDA | 10,051 | 11,566 | 12,244 | 12,432 | 11,940 |
Gross Margin | 64.4% | 68.8% | 68.0% | 67.6% | 66.9% |
Operating Margin | 16.7% | 16.5% | 17.6% | 17.9% | 17.1% |
ROA | 7.9% | 9.9% | 9.9% | 10.4% | 10.5% |
ROE | 12.3% | 14.6% | 14.6% | 15.0% | 15.0% |
Segment Performance
Unit: ¥M
2025
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| 化粧品事業 | 50,525 | 12,292 | 24.3% |
| 医薬・食品事業 | 11,535 | 980 | 8.5% |
| その他 | 2,664 | 301 | 11.3% |